Robert C Doebele

Robert C Doebele

University of Colorado Anschutz Medical Campus - - / United States
Others
AD Scientific Index ID: 1773597
University of Colorado School of Medicine
person_outline Robert C Doebele's MOST POPULAR ARTICLES
1-) Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenA Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ...New England Journal of Medicine 378 (8), 731-739, 201818692018
2-) Crizotinib in ROS1-rearranged non–small-cell lung cancerAT Shaw, SHI Ou, YJ Bang, DR Camidge, BJ Solomon, R Salgia, GJ Riely, ...New England Journal of Medicine 371 (21), 1963-1971, 201418542014
3-) Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trialsRC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ...The Lancet Oncology 21 (2), 271-282, 202012962020
4-) Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non–small cell lung cancerRC Doebele, AB Pilling, DL Aisner, TG Kutateladze, AT Le, AJ Weickhardt, ...Clinical cancer research 18 (5), 1472-1482, 201212932012
5-) Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncologyDS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ...Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 201712312017